Biologics Shown Effective in Real-World Setting for Managing Patients with Severe Chronic Rhinosinusitis with Nasal Polyps March 7, 2025 How do the clinical effects and response times of dupilumab, omalizumab, and mepolizumab compare when treating patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP)?